#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma recurrent Infection in an immunocompromised host Neurodegenerative disorder Inborn error of metabolism Pustular psoriasis Asthma Corneal neovascularisation Mitochondrial myopathy Chronic hepatitis B Phaeochromocytoma Leukaemia Adrenocortical carcinoma Hydrocephalus Synovial sarcoma recurrent Glomerulonephritis rapidly progressive More trials…

    Learn about Rare Diseases

    IgA nephropathy – Treatment Hereditary optic atrophy – Life with Disease Progressive supranuclear palsy – Life with Disease Adrenogenital syndrome Loeys-Dietz syndrome Castleman’s disease – Basic Information Krabbe’s disease – Treatment Haemophilia B with anti factor IX – Trials in Disease Rhabdomyosarcoma recurrent – Treatment Hereditary hypophosphataemic rickets More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Timothy Grass Pollen Extract Lna043 Warfarin Wt1 Mrna Dc Protease Abbv-668 Vinorelbine Bi 1291583 Tavapadon Clobetasol Propionate ACICLOVIR SODIUM GSKVX000000034796 Gs-1427 Zinc Oxide TAGRAXOFUSP Ponesimod Raxtozinameran Floxuridine Magnesium Sulfate Lovo-B More therapies…

    Learn about Your Condition

    Conjunctivitis allergic Rheumatoid arthritis Familial hypertriglyceridaemia Laparoscopic surgery Breast cancer stage II Fibromyalgia Hyperthyroidism Malignant melanoma of eyelid MELAS syndrome Progressive supranuclear palsy Peritoneal cancer index Angina pectoris Thrombocytosis Peripheral artery angioplasty Immunodeficiency congenital More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Treating Early Borderline Lesions in Low-Risk Kidney Transplant Patients with Rabbit Anti-T Lymphocyte Immunoglobulin

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Spain

  • Study of Lutetium-177 and Yttrium-90 DOTATATE combination therapy for patients with inoperable gastrointestinal neuroendocrine tumors

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dotatate
    • LUTETIUM LU-177
    • Yttrium-90
    Poland

  • Study on Adjusting Omalizumab Dosage for Patients with Severe Allergic Asthma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Omalizumab
    Spain

  • Study on Adjusting Adalimumab Treatment for Patients with Chronic Non-Infectious Uveitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infective uveitis
    Investigated Drugs:
    • Adalimumab
    France

  • Study on Durvalumab and Chemotherapy for Patients with Relapsed Stage III Non-Small Cell Lung Cancer After Chemoradiotherapy and Durvalumab Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Durvalumab
    Italy

  • Study on the Safety and Effectiveness of DT-DEC01 for Patients with Duchenne Muscular Dystrophy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Poland
Previous Page
1 … 812 813 814 815 816 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!